Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The many benefits of breastfeeding are well documented. However, because of the risk of
mother-to-child transmission (MTCT) of HIV from an HIV infected mother to her infant, there
is considerable concern over the practice, especially in developing countries. The purpose of
this study is to determine the safety and effectiveness of the anti-HIV drug nevirapine (NVP)
in preventing MTCT of HIV in breastfeeding infants born to HIV infected women in South
Africa, Tanzania, Uganda, and Zimbabwe.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institute of Mental Health (NIMH) National Institute on Drug Abuse (NIDA)